AstraZeneca partners with Oracle to bring AI into clinical trials
Photo: Cryptopolitan
Oracle announced that it has signed a non-binding agreement with AstraZeneca to test the potential for AI and real world patient data to find trial-eligible patients faster, aimed at easing recruitment, which remains the biggest bottleneck in drug research. The announcement came from Oracle’s corporate newsroom, with AstraZeneca also issuing its own release the same...
Source: Cryptopolitan
